Evidence map›Paper›PMID 25651996›Full record

ArticleMicrobial ecology in health and disease2015

The composition of the gut microbiota throughout life, with an emphasis on early life.

Juan Miguel Rodríguez, Kiera Murphy, Catherine Stanton, R Paul Ross, Olivia I Kober, Nathalie Juge, Ekaterina Avershina, Knut Rudi, Arjan Narbad, Maria C Jenmalm and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Microbial ecology in health and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 642 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
642citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03577119 nacompletednot on this mapstarted 2018, after this paper: background citation

Full-fat Yogurt and Glucose Tolerance

TypeinterventionalSponsorUniversity of Vermont Medical CenterRan2018 to 2022Enrolled13ConditionsPre-DiabetesArmsFull-fat yogurt, Non-fat yogurt
NCT06560879 phase2enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity and Changes in Gut Microbiota in Children With Acute Lymphoblastic Leukemia

TypeinterventionalSponsorNational Institute of Pediatrics, MexicoRan2025 to 2026Enrolled120ConditionsProbiotics, Gastrointestinal Diseases, Precursor Cell Lymphoblastic Leukemia-LymphomaArmsLactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Placebo
3 · Its place in the literature

Who cites it

642 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Gut microbiota modulation of systemic immunity and cancer immunotherapy: mechanisms, evidence, and therapeutic implications.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

582 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan Miguel RodríguezDepartment of Nutrition, Food Science and Food Technology, Complutense University of Madrid, Madrid, Spain.
Kiera MurphyAlimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
Catherine StantonAlimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
R Paul RossAlimentary Pharmabiotic Centre, University College Cork, Cork, Ireland.
Olivia I KoberThe Gut Health and Food Safety Institute Strategic Programme, Institute of Food Research, Norwich Research Park, Norwich, UK.
Nathalie JugeThe Gut Health and Food Safety Institute Strategic Programme, Institute of Food Research, Norwich Research Park, Norwich, UK.
Ekaterina AvershinaDepartment of Chemistry, Biotechnology and Food Sciences, Norwegian University of Life Sciences, Aas, Norway.
Knut RudiDepartment of Chemistry, Biotechnology and Food Sciences, Norwegian University of Life Sciences, Aas, Norway.
Arjan NarbadThe Gut Health and Food Safety Institute Strategic Programme, Institute of Food Research, Norwich Research Park, Norwich, UK.
Maria C JenmalmDepartment of Clinical and Experimental Medicine, Unit of Autoimmunity and Immune Regulation, Division of Clinical Immunology, Linköping University, Linköping, Sweden.
Julian R MarchesiSchool of Biosciences, Cardiff University, Cardiff, UK.
Maria Carmen ColladoDepartment of Biotechnology, Institute of Agrochemistry and Food Technology, Spanish National Research Council (IATA-CSIC), Valencia, Spain; mcolam@iata.csic.es.

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/00044452Biotechnology and Biological Sciences Research Council BBS/E/F/00044453
6 · The paper itself

Abstract

The intestinal microbiota has become a relevant aspect of human health. Microbial colonization runs in parallel with immune system maturation and plays a role in intestinal physiology and regulation. Increasing evidence on early microbial contact suggest that human intestinal microbiota is seeded before birth. Maternal microbiota forms the first microbial inoculum, and from birth, the microbial diversity increases and converges toward an adult-like microbiota by the end of the first 3-5 years of life. Perinatal factors such as mode of delivery, diet, genetics, and intestinal mucin glycosylation all contribute to influence microbial colonization. Once established, the composition of the gut microbiota is relatively stable throughout adult life, but can be altered as a result of bacterial infections, antibiotic treatment, lifestyle, surgical, and a long-term change in diet. Shifts in this complex microbial system have been reported to increase the risk of disease. Therefore, an adequate establishment of microbiota and its maintenance throughout life would reduce the risk of disease in early and late life. This review discusses recent studies on the early colonization and factors influencing this process which impact on health.

Indexed as

dietgutmaternalmicrobiotaneonate

Identifiers

PMID25651996
PMCPMC4315782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.